Menu
Share this

PPD Achieves Gold WELCOA Well Workplace Designation

03 Mar. 2010

RSS

WILMINGTON, N.C. (March 3, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has achieved national Gold Well Workplace designation by Wellness Councils of America (WELCOA), becoming one of only two North Carolina companies honored in 2009 for its commitment to protecting and enhancing the health and well-being of its employees.

Well Workplace designation is a rigorous process, which measures companies against seven health-focused benchmarks, including CEO support, creating cohesive wellness teams, data collection to drive health efforts, crafting an operating plan, choosing appropriate interventions, creating a supportive environment and consistently evaluating outcomes.

"The health and well-being of our employees are essential to our success, and one way we continually invest in our employees is by providing a cutting-edge wellness program," said Ed Murray, senior vice president of human resources. "We are pleased WELCOA has recognized our accomplishments, which we believe are an integral part of the culture necessary to recruit, develop and retain the brightest talent for PPD."

PPD's health and wellness campaigns include creative, engaging programs like Hoofin' Through the Holidays, a healthy holiday program, Biggest Loser, World No Tobacco Day and Kick Off Your Tailgate With Fruits and Vegetables, all designed to educate and empower employees to make healthy lifestyle choices.

"PPD has demonstrated its commitment to becoming one of America's healthiest companies, and WELCOA is pleased to recognize its excellence in workplace wellness programs with a gold designation," said David Hunnicutt, Ph.D., president of WELCOA.

Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about the spin-off and its anticipated benefits for PPD and Furiex Pharmaceuticals, are forward-looking statements that involve a number of risks and uncertainties. Although PPD and Furiex attempt to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: Furiex's lack of history as, and challenges operating as, an independent public company; anticipated losses and the potential need for Furiex to raise additional capital; its reliance on a limited number of products and product candidates; the ability to attract and retain key personnel; risks associated with the development and commercialization of drugs, including the ability to successfully launch and market a drug; the risk that safety issues might arise in the post-approval market; reliance on collaborators; competition in the market; rapid technological advances that make our products less competitive; and the other risk factors set forth from time to time in the Furiex Form 10 and other SEC filings, and in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.

Contact Us

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
PPD
Tel: +1 919 456 4425

Elizabeth Humphrey Corporate Communications Manager
PPD
Tel: +1 910 558 6096

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2017 Pharmaceutical Product Development, LLC. All rights reserved.